Invention Grant
- Patent Title: Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
-
Application No.: US13264973Application Date: 2010-04-17
-
Publication No.: US09617600B2Publication Date: 2017-04-11
- Inventor: David Dornan , Bart Burington
- Applicant: David Dornan , Bart Burington
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2010/031528 WO 20100417
- International Announcement: WO2010/121231 WO 20101021
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; A61K39/395 ; A61K39/00
Abstract:
The invention provides methods and kits useful for predicting or assessing responsiveness of a patient having B-cell lymphoma to treatment with anti-CD40 antibodies.
Public/Granted literature
- US20120123695A1 METHODS FOR ASSESSING RESPONSIVENESS OF B-CELL LYMPHOMA TO TREATMENT WITH ANTI-CD40 ANTIBODIES Public/Granted day:2012-05-17
Information query
